Department of Integrated Biosciences, Graduate School of Frontier Sciences, University of Tokyo, Chiba, Japan.
J Biol Chem. 2012 Nov 2;287(45):38080-9. doi: 10.1074/jbc.M112.394288. Epub 2012 Sep 17.
Malectin is an endoplasmic reticulum-resident lectin, which recognizes di-glucosylated Glc(2)Man(9)GlcNAc(2) (G2M9) N-glycans on newly synthesized glycoproteins. We previously demonstrated that malectin preferentially associates with misfolded glycoproteins and inhibits their secretion (Chen, Y., Hu, D., Yabe, R., Tateno, H., Qin, S. Y., Matsumoto, N., Hirabayashi, J., and Yamamoto, K. (2011) Mol. Biol. Cell 22, 3559-3570). The sugar binding activity of malectin is required for this process. However, because G2M9 N-glycans are generated at the very early stage of processing and are typically found on both misfolded glycoproteins and glycoproteins undergoing folding, other mechanisms must underlie the preference of malectin for misfolded glycoproteins. Here, we searched for proteins that were co-immunoprecipitated with malectin, and we found that malectin formed a stable complex with an endoplasmic reticulum-resident transmembrane protein, ribophorin I. Co-expression of malectin and ribophorin I significantly enhanced the association between malectin and a folding-defective α1-antitrypsin variant (null Hong Kong) and reduced its secretion; however, secretion of wild-type α1-antitrypsin was not affected. The enhanced association and reduced secretion were counteracted by siRNA-mediated down-regulation of ribophorin I. Also, a reporter assay revealed that ribophorin I preferentially interacted with misfolded ribonuclease A but not with the native form, suggesting that ribophorin I may function as a chaperone that recognizes misfolded proteins inside cells. These results provide the first evidence of the mechanism by which malectin preferentially associates with misfolded glycoproteins.
凝集素是内质网驻留的凝集素,它识别新合成糖蛋白上的双葡萄糖基化 Glc(2)Man(9)GlcNAc(2) (G2M9) N-聚糖。我们之前证明凝集素优先与错误折叠的糖蛋白结合,并抑制它们的分泌(Chen,Y.,Hu,D.,Yabe,R.,Tateno,H.,Qin,S. Y.,Matsumoto,N.,Hirabayashi,J.,and Yamamoto,K.(2011)Mol. Biol. Cell 22, 3559-3570)。凝集素的糖结合活性是这个过程所必需的。然而,由于 G2M9 N-聚糖是在加工的早期阶段产生的,并且通常存在于错误折叠的糖蛋白和正在折叠的糖蛋白上,因此必须有其他机制来解释凝集素对错误折叠的糖蛋白的偏好。在这里,我们搜索了与凝集素共免疫沉淀的蛋白质,发现凝集素与内质网驻留的跨膜蛋白核糖体蛋白 I 形成稳定的复合物。凝集素和核糖体蛋白 I 的共表达显著增强了凝集素与折叠缺陷型α1-抗胰蛋白酶变异体(无效香港)之间的关联,并减少了其分泌;然而,野生型α1-抗胰蛋白酶的分泌不受影响。通过 siRNA 介导的核糖体蛋白 I 下调,增强的关联和减少的分泌被抵消。此外,报告基因实验表明,核糖体蛋白 I 优先与错误折叠的核糖核酸酶 A 相互作用,而不是与天然形式相互作用,这表明核糖体蛋白 I 可能作为一种伴侣蛋白,在细胞内识别错误折叠的蛋白质。这些结果提供了凝集素优先与错误折叠的糖蛋白结合的机制的第一个证据。